☆ 4.4 Article

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)

Get Full Text
Add to Collection

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
Volume 66, Issue 27, Pages 734-737

Publisher

CENTERS DISEASE CONTROL
DOI: 10.15585/mmwr.mm6627e1

Keywords

-

Categories

Public, Environmental & Occupational Health

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.